We are live on !
Find out more
UBS Portfolio holdings
AUM
$136B
Turnover
18.95%
1-Year Est. Return
16.36%
This Fund
S&P 500
This Quarter Est. Return
-0.23%
1 Year Est. Return
+16.36%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$136B
AUM Growth
+$7.83B
(+6.1%)
Cap. Flow
+$3.56B
Cap. Flow % of AUM
Cap. Flow %
2.62%
Top 10 Holdings %
Top 10 Hldgs %
13.26%
Holding
11,505
New
1,064
Increased
4,754
Reduced
3,910
Closed
1,116
Avg Time Held
Equity + Options
1
year
Top 10 Avg Time Held
Equity + Options
0.8
years
Top 20 Avg Time Held
Equity + Options
0.8
years
Avg Time Held Equity only
1
year
Top 10 Avg Time Held Equity only
0.9
years
Top 20 Avg Time Held Equity only
1
year
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$387M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$346M |
| 3 |
Crown Castle
CCI
|
+$229M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$218M |
| 5 |
Toronto Dominion Bank
TD
|
+$195M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.62B |
| 2 |
APA Corp
APA
|
+$473M |
| 3 |
FDO
FAMILY DOLLAR STORES
FDO
|
+$453M |
| 4 |
Herc Holdings
HRI
|
+$322M |
| 5 |
PETM
PETSMART INC
PETM
|
+$311M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 47.72% |
| 2 | Energy | 9.22% |
| 3 | Financials | 6.8% |
| 4 | Healthcare | 6.74% |
| 5 | Technology | 6.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
ACHN
3201
CALL
DELISTED
Achillion Pharmaceuticals
ACHN
| $1.45M | ﹤0.01% |
145,100
+61,200
| +73% | +$568K |
2013 Q2
5 quarters
|
|
|
DRC
3202
PUT
DELISTED
DRESSER-RAND GROUP INC
DRC
| $1.45M | ﹤0.01% |
17,600
+17,400
| +8,700% | +$1.17M |
2013 Q2
5 quarters
|
|
3203
PUT
T-Mobile US
TMUS
$157B
| $1.45M | ﹤0.01% |
50,100
-160,500
| -76% | -$4.94M |
2013 Q2
5 quarters
|
|
|
SC
3204
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $1.44M | ﹤0.01% |
80,917
-25,510
| -24% | -$482K |
2014 Q1
2 quarters
|
|
3205
Cimpress
CMPR
$1.96B
| $1.44M | ﹤0.01% |
26,292
+7,018
| +36% | +$321K |
2013 Q2
5 quarters
|
|
3206
Anika Therapeutics
ANIK
$287M
| $1.44M | ﹤0.01% |
39,231
-7,813
| -17% | -$338K |
2013 Q2
5 quarters
|
|
|
SFG
3207
DELISTED
STANCORP FINL GRP
SFG
| $1.44M | ﹤0.01% |
22,707
-2,731
| -11% | -$173K |
2013 Q2
5 quarters
|
|
3208
CALL
Marriott International
MAR
$102B
| $1.43M | ﹤0.01% |
20,500
-5,200
| -20% | -$352K |
2013 Q2
5 quarters
|
|
3209
CVB Financial
CVBF
$4.02B
| $1.43M | ﹤0.01% |
99,792
-79
| -0.1% | -$1.22K |
2013 Q2
5 quarters
|
|
3210
Pimco California Municipal Income Fund
PCQ
$150M
| $1.43M | ﹤0.01% |
99,967
+9,996
| +11% | +$144K |
2013 Q2
5 quarters
|
|
3211
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$322M
| $1.43M | ﹤0.01% |
25,387
-102,192
| -80% | -$5.95M |
2013 Q2
5 quarters
|
|
3212
Arq
ARQ
$76.4M
| $1.43M | ﹤0.01% |
67,181
+17,924
| +36% | +$390K |
2013 Q2
5 quarters
|
|
|
BSD
3213
DELISTED
The BlackRock Strategic Municipal Trust
BSD
| $1.43M | ﹤0.01% |
107,544
+34,319
| +47% | +$454K |
2013 Q2
5 quarters
|
|
3214
Arthur J. Gallagher & Co
AJG
$68.7B
| $1.43M | ﹤0.01% |
31,454
+938
| +3% | +$43.1K |
2013 Q2
5 quarters
|
|
3215
PUT
General Mills
GIS
$18.4B
| $1.43M | ﹤0.01% |
28,300
+11,300
| +66% | +$593K |
2013 Q2
5 quarters
|
|
3216
Blackbaud
BLKB
$2.52B
| $1.43M | ﹤0.01% |
36,300
+1,526
| +4% | +$56.8K |
2013 Q2
5 quarters
|
|
3217
PUT
Invesco DB Agriculture Fund
DBA
$1.2B
| $1.43M | ﹤0.01% |
55,800
+43,900
| +369% | +$1.15M |
2013 Q2
5 quarters
|
|
|
NXQ
3218
DELISTED
NUVEEN ELECT TAX-FREE INC 2
NXQ
| $1.43M | ﹤0.01% |
107,751
+10,169
| +10% | +$136K |
2013 Q2
5 quarters
|
|
3219
Nuveen Quality Municipal Income Fund
NAD
$2.41B
| $1.42M | ﹤0.01% |
102,949
-2,215
| -2% | -$30.6K |
2013 Q2
5 quarters
|
|
3220
Weibo
WB
$1.52B
| $1.42M | ﹤0.01% |
76,213
+28,249
| +59% | +$565K |
2014 Q2
1 quarter
|
|
|
MYC
3221
DELISTED
Blackrock Muni Yield California Fund, Inc.
MYC
| $1.42M | ﹤0.01% |
94,073
+33,601
| +56% | +$504K |
2013 Q2
5 quarters
|
|
3222
CALL
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $1.42M | ﹤0.01% |
950
+608
| +178% | +$880K |
2013 Q3
4 quarters
|
|
3223
First Trust Alerian Disruptive Technology Real Estate ETF
DTRE
$14M
| $1.42M | ﹤0.01% |
34,506
-561
| -2% | -$24.3K |
2013 Q2
5 quarters
|
|
3224
Tejon Ranch
TRC
$445M
| $1.42M | ﹤0.01% |
52,278
+1,467
| +3% | +$41.3K |
2013 Q2
5 quarters
|
|
3225
PUT
DELISTED
Marathon Oil Corporation
MRO
| $1.42M | ﹤0.01% |
37,800
-62,800
| -62% | -$2.49M |
2013 Q2
5 quarters
|
|
Similar funds
MGC
UBS's Q3 2014 Portfolio in Review
As of Q3 2014, UBS held 11,505 positions worth $136B, up 6.1% from $128B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS's Q3 2014 filing shows 1,064 new, 4,754 increased, 3,910 reduced and 1,116 closed positions. Its largest new stake was Alibaba: 1,105,926 shares worth $98.3M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.62B.
By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, up from 47% a quarter earlier, followed by Energy and Financials.
- UBS's largest Q3 2014 buy was Alibaba: 1,105,926 shares worth $98.3M.
- UBS added most to Amgen in Q3 2014, an estimated $387M increase.
- UBS's biggest Q3 2014 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.62B.
- UBS fully exited SUSSER HOLDINGS CORPORATION COMMON STOCK in Q3 2014, selling an estimated $81.1M.
- UBS's ten largest holdings make up 13% of its $136B portfolio in Q3 2014.
- UBS opened 1,064 new positions and closed 1,116 in Q3 2014.
- UBS's portfolio value rose 6.1% quarter-over-quarter to $136B.
Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.